Background: The role of remdesivir in the treatment of hospitalized patients with COVID-19
remains ill-defined. We conducted a cost-effectiveness analysis alongside the Canadian …

Objectives This study aimed to estimate the cost-effectiveness of remdesivir, the first novel
therapeutic to receive Emergency Use Authorization for the treatment of hospitalized …

Introduction In addition to significant morbidity and mortality, the coronavirus disease
(COVID-19) has strained health care systems globally. This study investigated the cost …

Background The coronavirus disease 2019 (COVID-19) pandemic has been a global health
emergency since December 2019, leading to millions of deaths worldwide and placing …

Objectives In the ACTT-1 study in hospitalized adults with laboratory confirmed COVID-19,
remdesivir was found to be superior to placebo in shortening time to recovery from COVID …

Background Remdesivir (RDV) improved clinical outcomes among hospitalized patients with
coronavirus disease 2019 (COVID-19) in randomized trials, but data from clinical practice …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of SARS-CoV-2. Methods This was a retrospective comparative …

Background Remdesivir is being studied and used to treat coronavirus disease 2019
(COVID-19). This study aimed to systematically identify, critically evaluate, and summarize …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Background: The role of remdesivir in the treatment of patients in hospital with COVID-19
remains ill defined in a global context. The World Health Organization Solidarity randomized …